03681.HK
SinoMab BioScience Limited
HKSE · Healthcare · Biotechnology · HK
HKD 1.13
−2.17%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-50.3%
Return on equity
-26.6%
Return on assets
-25.4%
Return on invested capital
0.00x
Asset turnover
-HKD 82.4M
Cash from operations
HKD 0.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026